Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
1055 Views
Dr KK Aggarwal 11 May 2020
(With inputs from Dr Monica Vasudev)
830: Three drugs better
Patients hospitalized with COVID-19 receiving a combination therapy with three antivirals, including-protease inhibitor lopinavir-ritonavir (Kaletra), nucleoside analogue ribavirin, and injectable interferon beta-1b (Betaseron, Extavia), exhibited significantly shorter median time to a negative SARS-CoV-2 test compared to controls, revealed a small phase II trial. Median number of days from initiation of study treatment to a negative test result, the trials primary endpoint, was 7 days compared with 12 days in the control group that only received lopinavir-ritonavir, reported Kwok-Yung Yuen, MD, of the University of Hong Kong, and colleagues writing in The Lancet.
831: COVID formulas revisited
Documented PCR-positive COVID-19 cases are just the tip of the iceberg.
Steamroller COVID: There were roughly two undocumented cases of COVID-19 for each documented case in a paper from Iceland. This implies that a ton of people are still susceptible to the disease. No herd immunity is developing, and the mortality rate is high, and that were going to be stuck inside for a long time.
However, of late, using antibody tests, researchers are sampling asymptomatic people to figure out who had the disease. In early April, researchers from Germany published a study, which found that 70 out of 500 people tested in a hard-hit area had coronavirus antibodies. That amounts to 14%. Translating that to the entire population puts the ratio of undocumented to documented COVID-19 at about 5 to 1.
A much criticized California seroprevalence study involving 3300 individuals noted that 50 were positive, amounting to merely 1.5%, but in an area that hadnt seen many symptomatic cases, putting the undocumented-to-documented ratio at 85 to 1.
Windstorm COVID: Governor Andrew Cuomo reported that sampling of New York City grocery store shoppers (perhaps not the most random sample) exhibited a seroprevalence rate of about 20%. This translates to an undocumented-to-documented ratio of 10 to 1. This scenario allows us to open up more quickly, assuming that antibodies are protective.
So which COVID is it?
Antibody tests: No test is perfect. The false positives are particularly high. Consider that you have an antibody test that is 98% specific. This means that only 2 out of 100 people will go on to have a false positive. It will be estimated that 2% of the population has had the disease. If that is done in a random sample of America, youd estimate that there have been 6 million coronavirus infections, compared with the roughly 1 million weve detected, thus allowing you to cut the death rate down by a factor of 6.
However, that result was just due to random chance. A 95% specific test would conclude that at least 15 million Americans have already had exposure, allowing you to take the observed death rate of 5.7% and reduce it to a much more comfortable 0.3%.
832: Mutation: Scientists have cautioned that a mutation called D614G in the Spike protein region of the SARS-CoV-2 virus “is of urgent concern,” as it makes the virus more contagious.
Dr KK Aggarwal
Dr K K Aggarwal, President CMAAO, HCFI, Past National President IMA, Chief Editor Medtalks
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}